Researchers wrote in 2011 that one of the most important functions of endocannabinoids and CB(1) receptors are to enhance the energy storage conversion into fat and reduce energy expenditure by influencing both lipid and glucose metabolism. Although normally well controlled by hormones etc., the endocannabinoid regulation of energy balance can become dysregulated and contribute to obesity, dyslipidemia and diabetes (type 2).
In 2013, a team of four medical researchers lead by Dr. Elizabeth Penner MD, MPH, carried out a clinical study with over 4,500 participants, called “The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults”. They concluded: “We found that marijuana use was associated with lower levels of fasting insulin and HOMA-IR, and smaller waist circumference.”

On the plus side, there is an earnest desire for people to lose weight, which is why the weight loss industry is worth an astonishing $66 billion! But this staggering number, added to the fact that fewer people are dieting and more are gaining weight, tells us two things: One, that weight loss supplements are fundamentally ineffective; and two, that they are very, very expensive.


On the plus side, there is an earnest desire for people to lose weight, which is why the weight loss industry is worth an astonishing $66 billion! But this staggering number, added to the fact that fewer people are dieting and more are gaining weight, tells us two things: One, that weight loss supplements are fundamentally ineffective; and two, that they are very, very expensive.
Frankel puts his hand on his heart. “Imagine the pressure!” he says. A complex soul, whose parents survived the Holocaust, Frankel says that when his patients don’t get better, he’s sad and disappointed, and starts to question if he’s wasting people’s time and money. “But then ten people will get better, and I feel… grateful. It makes me confident I’m on the right road, on the right side of history.”
Recent evidence from animal and human studies shows a role for the endocannabinoid system in maintaining energy balance and glucose as well as lipoprotein metabolism, according to a 2009 study. Modulation of this system has resulted in an improvement in a number of important risk factors in clinical trials, including visceral and subcutaneous abdominal adipose tissue, glucose tolerance, dyslipidemia and measures of inflammation.
Hemplucid uses domestically sourced full-spectrum CBD to make this tincture. It includes a medium-chain triglyceride carrier MCT oil as part of the formula. This product contains terpenes and nearly undetectable levels of THC. The ingredients are all-natural, and they come from hemp plants that are bred for almost ten years to ensure a high level of cannabinoids. This product is certified as organic, and it does not contain GMOs.

Frankel grew plants, crossed strains, and tried them on friends as well as himself. Working with chemists and professional growers, he developed formulas for whole plant oils, which are manufactured independently and for which he receives no compensation. In 2006, Frankel felt he’d learned enough to open a new practice as a cannabis medical consultant.


When the endocannabinoid system becomes dysregulated, it often becomes overactive and too much fat is being stored, particularly in the intra-abdominal tissue. Cannabidiol is known to regulate the endocannabinoid system as it can restore balance in both directions. Therefore, the study concludes that, along with lifestyle changes cannabis could be a means of fighting obesity.
He did exhaustive research. He found there’d been decades of scientific studies on the effects of THC and CBD on cells and animals, but few trials with humans, because the FDA classifies cannabis and all its components as Schedule 1 drugs, which have “no accepted medical treatment use.” It took Sue Sisley, an Arizona physician, seven years of struggling with bureaucratic hurdles before she received the first FDA approval for a study, just beginning, of marijuana with vets who have PTSD.
© iDWeeds - Consult your (Cannabis) physician before use. CBD can potentially interact with many pharmaceuticals. iDWeeds is an educational cannabinoid resource driven by its users feedback and scientific research. We do not sell or distribute any CBD/cannabis products. We solely review CBD brands based on third-party lab tests to protect users from CBD frauds. Read our full disclaimer. 
×